Wedbush Maintains Outperform on Tyra Biosciences, Raises Price Target to $57
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice Target
Wedbush analyst Robert Driscoll maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $53 to $57.
Wedbush analyst Robert Driscoll maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $53 to $57.